Back to Search
SRIDHAR MANI, MD
MD
Medical Oncology Physician
NPI: 1922188416Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
186785(NY)
Research & Publications (20)
Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.
PMID 19239394·Expert Opin Drug Metab Toxicol·2009
6-review
Activation of the steroid and xenobiotic receptor (human pregnane X receptor) by nontaxane microtubule-stabilizing agents.
PMID 16144941·Clin Cancer Res·2005
7-preclinical
The clinical development of new mitotic inhibitors that stabilize the microtubule.
PMID 15205596·Anticancer Drugs·2004
6-review
Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors.
PMID 14977827·Clin Cancer Res·2004
3-trial
Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.
PMID 14751840·Ann N Y Acad Sci·2003
8-other
UGT1A1 polymorphism predicts irinotecan toxicity: evolving proof.
PMID 11783425·AAPS PharmSci·2001
8-other
Cyclin-dependent kinase inhibitors: novel anticancer agents.
PMID 11060782·Expert Opin Investig Drugs·2000
6-review
A hydrophilic lamin-binding domain from the Drosophila YA protein can target proteins to the nuclear envelope.
PMID 12679383·J Cell Sci·2003
7-preclinical
Failure to express GAP-43 during neurogenesis affects cell cycle regulation and differentiation of neural precursors and stimulates apoptosis of neurons.
PMID 11161469·Mol Cell Neurosci·2001
7-preclinical
Targeted disruption of GAP-43 in P19 embryonal carcinoma cells inhibits neuronal differentiation. As well as acquisition of the morphological phenotype.
PMID 10640639·Brain Res·2000
7-preclinical
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.
PMID 19572105·Invest New Drugs·2010
3-trial
Clinical utility of the modified segmental boost technique for treatment of the pelvis and inguinal nodes.
PMID 19596174·Int J Radiat Oncol Biol Phys·2010
8-other
Design, synthesis and biological evaluation of 2H-benzo[b][1,4] oxazine derivatives as hypoxia targeted compounds for cancer therapeutics.
PMID 19515559·Bioorg Med Chem Lett·2009
8-other
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.
PMID 19509177·Clin Cancer Res·2009
3-trial
Chronic administration of KB-R7943 induces up-regulation of cardiac NCX1.
PMID 19661061·J Biol Chem·2009
7-preclinical
Percutaneous external jugular vein catheterization in piglets using a triangulation technique.
PMID 19535391·Lab Anim·2009
7-preclinical
Histone deacetylases facilitate sodium/calcium exchanger up-regulation in adult cardiomyocytes.
PMID 19638401·FASEB J·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MMC - DEPT. OF ONCOLOGY, 1695 EASTCHESTER ROAD
BRONX, NY 10461 - Phone
- (718) 405-8505
Quick Facts
- NPI
- 1922188416
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile